Eli Lilly and Company – Strategy, SWOT and Corporate Finance Report

Eli Lilly and Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Eli Lilly and Company (Eli Lilly or 'the company') is engaged in developing, manufacturing, and marketing pharmaceutical products and animal health products. The company classifies its business into two business segments: Human Pharmaceutical Products and Animal Health Products. Through these businesses, the company offers human pharmaceutical products in the therapeutic areas of neuroscience, endocrinology, oncology, cardiovascular, and immunology. It also develops, manufactures, and markets products for both food animals and companion animals. The company operates in the US, Japan, Europe and other countries. The company is headquartered in Indianapolis, Indiana.

Scope

– Detailed information on Eli Lilly and Company required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Eli Lilly and Company in the form of a SWOT analysis

– An in-depth view of the business model of Eli Lilly and Company including a breakdown and examination of key business segments

– Intelligence on Eli Lilly and Company's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Eli Lilly and Company, such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Eli Lilly and Company and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Eli Lilly and Company as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Eli Lilly and Company's business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Table of Contents

Eli Lilly and Company: Company Overview

Eli Lilly and Company: Overview and Key Facts

Eli Lilly and Company: Overview

Eli Lilly and Company: Key Facts

Eli Lilly and Company: Key Employees

Eli Lilly and Company: Key Employee Biographies

Eli Lilly and Company: Major Products and Services

Eli Lilly and Company: Company History

Eli Lilly and Company: Management Statement

Eli Lilly and Company: Locations and Subsidiaries

Eli Lilly and Company: Key Competitors

Eli Lilly and Company: Company Analysis

Eli Lilly and Company: Business Description

Eli Lilly and Company: SWOT Analysis

Eli Lilly and Company: SWOT Overview

Eli Lilly and Company: Strengths

Eli Lilly and Company: Weaknesses

Eli Lilly and Company: Opportunities

Eli Lilly and Company: Threats

Eli Lilly and Company: Corporate Financial Deals Activity

Eli Lilly and Company: Financial Deals Overview

Eli Lilly and Company: Targets and Partners

Eli Lilly and Company: Top Deals 2015 - 2019YTD*

Eli Lilly and Company: Advisors

Eli Lilly and Company: Top Legal Advisors

Eli Lilly and Company: Top Financial Advisors

Eli Lilly and Company: Mergers and Acquisitions

Eli Lilly and Company: Corporate Venturing

Eli Lilly and Company: Capital Raising

Eli Lilly and Company: Partnership

Eli Lilly and Company: Divestments

Eli Lilly and Company: Recent Developments

Eli Lilly and Company: News and Events Summary

Eli Lilly and Company: Business Reorganization

Eli Lilly and Company: Contracts

Eli Lilly and Company: Corporate Governance

Eli Lilly and Company: Market Developments

Eli Lilly and Company: Regulatory and Legal Events

Eli Lilly and Company: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Eli Lilly and Company: Key Facts

Table 2: Eli Lilly and Company: Key Employees

Table 3: Eli Lilly and Company: Company History

Table 4: Eli Lilly and Company: Locations and Subsidiaries

Table 5: Eli Lilly and Company: Key Competitors

Table 6: Eli Lilly and Company: Deal Activity by Deal Type – Volume (TTM*)

Table 7: Eli Lilly and Company: M&A Activity by Geography (TTM*)

Table 8: Eli Lilly and Company: Deal Activity by Deal Type – Volume (2015 – YTD*2019)

Table 9: Eli Lilly and Company: M&A Average Deal Size – Value (US$m)

Table 10: Eli Lilly and Company: Targets and Partners

Table 11: Eli Lilly and Company: Top Deals 2015 – 2019YTD*

Table 12: Eli Lilly and Company: Legal Advisor Ranking by Value (US$m)

Table 13: Eli Lilly and Company: Financial Advisor Ranking by Value (US$m)

Table 14: Eli Lilly and Company: M&A Volume and Value Trend (2015 – YTD*2019)

Table 15: Eli Lilly and Company: M&A Activity by Geography (2015 – YTD*2019)

Table 16: Eli Lilly and Company: Corporate Venturing Volume and Value Trend (2015 – YTD*2019)

Table 17: Eli Lilly and Company: Corporate Venturing by Geography (2015 – YTD*2019)

Table 18: Eli Lilly and Company: Capital Raising Volume and Value Trend (2015 – YTD*2019)

Table 19: Eli Lilly and Company: Capital Raising by Deal Type (2015 – YTD*2019)

Table 20: Eli Lilly and Company: Partnership Volume and Value Trend (2015 – YTD*2019)

Table 21: Eli Lilly and Company: Partnership Trend by Deal Type (2015 – YTD*2019)

Table 22: Eli Lilly and Company: Divestments Volume and Value Trend (2015 – YTD*2019)

Table 23: Eli Lilly and Company: Divestments by Geography (2015 – YTD*2019)

Table 24: Eli Lilly and Company: News and Events Summary

Table 25: Eli Lilly and Company: Business Reorganization

Table 26: Eli Lilly and Company: Contracts

Table 27: Eli Lilly and Company: Corporate Governance

Table 28: Eli Lilly and Company: Market Developments

Table 29: Eli Lilly and Company: Regulatory and Legal Events

Table 30: Eli Lilly and Company: Strategy and Operations

List of Figures

List of Figures

Figure 1: Eli Lilly and Company: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Eli Lilly and Company: M&A Activity by Geography (TTM*)

Figure 3: Eli Lilly and Company: Deal Activity by Deal Type – Volume (2015 – YTD*2019)

Figure 4: Eli Lilly and Company: M&A Average Deal Size – Value (US$m)

Figure 5: Eli Lilly and Company: M&A Volume and Value Trend (2015 – YTD*2019)

Figure 6: Eli Lilly and Company: M&A Activity by Geography (2015 – YTD*2019)

Figure 7: Eli Lilly and Company: Corporate Venturing Volume and Value Trend (2015 – YTD*2019)

Figure 8: Eli Lilly and Company: Corporate Venturing by Geography (2015 – YTD*2019)

Figure 9: Eli Lilly and Company: Capital Raising Volume and Value Trend (2015 – YTD*2019)

Figure 10: Eli Lilly and Company: Capital Raising by Deal Type (2015 – YTD*2019)

Figure 11: Eli Lilly and Company: Partnership Volume and Value Trend (2015 – YTD*2019)

Figure 12: Eli Lilly and Company: Partnership Trend by Deal Type (2015 – YTD*2019)

Figure 13: Eli Lilly and Company: Divestments Volume and Value Trend (2015 – YTD*2019)

Figure 14: Eli Lilly and Company: Divestments by Geography (2015 – YTD*2019)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports